It is a pharma private limited company based in Pune, Maharashtra, India, established in 2022.
2022 | Pune, Maharashtra, India | ActiveExtermis Pharmaceutical Private Limited, a active private limited company, was established on 17 November 2022 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24304PN2022PTC216187. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹50.00 K .
It upholds a compliant status. Its leadership includes Pratik Bhagavat Kadao (Director), Kaveri Maulik Kadao (Director), Bhagvat Narayan Kadav (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S. No. 130/2, Flat No 408, The Prest Avenue, Baner, Pune City, Pune (Cb), Pune, Maharashtra, 411021.
U24304PN2022PTC216187
216187
17 November 2022
₹0.40 M
₹50.00 K
Roc Pune
Unlisted
Active
Explore comprehensive insights into Extermis Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratik Bhagavat Kadao | Director | 06 Apr 2024 | Current |
| Kaveri Maulik Kadao | Director | 17 Nov 2022 | Current |
| Bhagvat Narayan Kadav | Director | 17 Nov 2022 | Current |
| Sujata Sandeep Deo | Director | 11 Feb 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Extermis Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Extermis Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Extermis Pharmaceutical has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Extermis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Extermis Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sujata Sandeep Deo was appointed as a Director was appointed as a Director on 11 Feb 2025 & has been associated with this company since 10 months 13 days . was completed.
The activity Extermis Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Pratik Bhagavat Kadao was appointed as a Director was appointed as a Director on 06 Apr 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
The activity Extermis Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
The activity Kaveri Maulik Kadao was appointed as a Director was appointed as a Director on 17 Nov 2022 & has been associated with this company since 3 years 1 month . was completed.
Progress on Bhagvat Narayan Kadav was appointed as a Director was appointed as a Director on 17 Nov 2022 & has been associated with this company since 3 years 1 month . was documented.
The CIN of Extermis Pharmaceutical Private Limited is U24304PN2022PTC216187.
Extermis Pharmaceutical Private Limited is headquartered at S. No. 130/2, Flat No 408, The Prest Avenue, Baner, Pune City, Pune (Cb), Pune, Maharashtra, 411021.
Extermis Pharmaceutical Private Limited was incorporated on 17 November 2022.
The current directors of Extermis Pharmaceutical Private Limited are
The primary industry of Extermis Pharmaceutical Private Limited is Pharma.
Extermis Pharmaceutical Private Limited is unlisted.
The authorized capital of Extermis Pharmaceutical Private Limited is ₹0.40 M, and the paid-up capital is ₹50.00 K .
The compliance status of Extermis Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX